Electroencephalography

Study of the Efficacy of Neurofeedback Training on Chemotherapy-Induced Neuropathy Receives 2018 FNAN Award

Retrieved on: 
星期一, 五月 21, 2018

Estimates of this incidence of chemotherapy-induced peripheral neuropathy (CIPN) after treatment can range as high as 71% to 96%.

Key Points: 
  • Estimates of this incidence of chemotherapy-induced peripheral neuropathy (CIPN) after treatment can range as high as 71% to 96%.
  • Each patient in the neurofeedback group received twenty sessions of training based on their own qEEG pattern.
  • This study shows that neurofeedback can offer an alternative to pain medication which is well accepted by patients."
  • FNAN awards its prize for the best neurofeedback article on an annual basis.

Brain Computer Interface Market to be Worth US$ 1.2 Billion by 2024; Demand Increases with Growing Prevalence of Brain Disorders - TMR

Retrieved on: 
星期三, 五月 16, 2018

Presence of ruling competitors such as NeuroPace Inc., MindMaze SA, and Emotiv Systems could be marked in the market.

Key Points: 
  • Presence of ruling competitors such as NeuroPace Inc., MindMaze SA, and Emotiv Systems could be marked in the market.
  • TMR prognosticates the global brain computer interface market to post a 14.9% CAGR for the forecast tenure 2016-2024.
  • Consumers are prophesied to adopt brain computer interface technology due to increasing awareness about its utility through various advertisements and programs.
  • The market is segmented into the following categories for better comprehension:
    Global Brain Computer Interface Market: Type

Michael Turchotte Joins Vitalus Health as The Vice President of Payor Strategies

Retrieved on: 
星期二, 五月 1, 2018

HOUSTON, May 1, 2018 /PRNewswire-iReach/ -- Vitalus Health is proud to announce and welcome Michael Turcotte as the company's Vice President of Payor Strategies.

Key Points: 
  • HOUSTON, May 1, 2018 /PRNewswire-iReach/ -- Vitalus Health is proud to announce and welcome Michael Turcotte as the company's Vice President of Payor Strategies.
  • Michael is a seasoned executive with skills ranging from Sales Management, to Finance, to General Management with P&L Responsibility.
  • He has held many leadership positions that include Business Owner, Subsidiary President, Regional Vice President, and National Director all within the health care product and service industry.
  • Vitalus Health provides specialty lung disease management, comprehensive sleep diagnostic solutions, PAP therapy, EEG testing, and home health care.

Global Epilepsy Report 2018 - Epiomic Epidemiology Forecasts to 2028

Retrieved on: 
星期二, 四月 24, 2018

The "Epiomic Epidemiology Series: Epilepsy Forecast In 19 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Epiomic Epidemiology Series: Epilepsy Forecast In 19 Major Markets 2018-2028" report has been added to ResearchAndMarkets.com's offering.
  • This report provides the current prevalent population for epilepsy across 19 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Russia, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort.
  • In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.
  • Epilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types according to clinical and EEG features.